-
Je něco špatně v tomto záznamu ?
European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[Formula: see text]
Writing group:, I. Nunes, C. Dupont, S. Timonen, Guideline panel:, D. Ayres de Campos, V. Cole, C. Schwarz, A. Kwee, B. Yli, C. Vayssiere, GE. Roth, E. Gliozheni, Y. Savochkina, M. Ivanisevic, P. Janku, S. Timonen, G. Daskalakis, A. Beke, S....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- císařský řez MeSH
- indukovaný porod * MeSH
- lidé MeSH
- misoprostol MeSH
- novorozenec MeSH
- oxytocin terapeutické užití MeSH
- perinatální péče MeSH
- těhotenství MeSH
- uterotonika * terapeutické užití MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OF RECOMMENDATIONS1. Oxytocin for induction or augmentation of labor should not be started when there is a previous scar on the body of the uterus (such as previous classical cesarean section, uterine perforation or myomectomy when uterine cavity is reached) or in any other condition where labor or vaginal delivery are contraindicated. (Moderate quality evidence +++-; Strong recommendation).2. Oxytocin should not be started before at least 1 h has elapsed since amniotomy, 6 h since the use of dinoprostone (30 min if vaginal insert) and 4 h since the use of misoprostol (Low quality evidence ++- -; Moderate recommendation).3. Cardiotocography (CTG) should be performed and a normal pattern without tachysystole should be documented for at least 30 min before oxytocin is used. Continuous CTG, with adequate monitoring of both fetal heart rate and uterine contractions, should be maintained for as long as oxytocin is used, and thereafter until delivery (Low ++- - to moderate +++- quality evidence; Strong recommendation).4. For labor induction, at least 1-h should be allowed after amniotomy before oxytocin infusion is started, to evaluate whether adequate uterine contractility has meanwhile ensued. For augmentation of labor, if the membranes are intact and there are conditions for a safe amniotomy, the latter should be considered before oxytocin is started (Very low quality evidence +- --; Weak recommendation).5. Oxytocin should be administered intravenously using the following regimen: 5 IU oxytocin diluted in 500 mL of 0.9% normal saline (NaCl) (each mL contains 10 mIU of oxytocin), in an infusion pump at increasing rates, as shown in Table 1, until a frequency of 3-4 contractions per 10 min is reached, a non-reassuring CTG pattern ensues, or maximum rates are reached (Low quality evidence ++ - -; Strong recommendation). If the frequency of contractions exceeds 5 in 10 min, the infusion rate should be reduced, even if a normal CTG pattern is present. With a non-reassuring CTG pattern, urgent clinical assessment by an obstetrician is indicated, and strong consideration should be given to reducing or stopping the oxytocin infusion. The minimal effective dose of oxytocin should always be used. (Low ++- - to Moderate +++- - quality evidence; Strong recommendation).[Table: see text]6. Use of oxytocin for induction and augmentation of labor should be regularly audited (Low quality evidence ++--; Strong recommendation).
AURORE Perinatal Network Hospices Civils de Lyon Croix Rousse Hospital Lyon France
Delivery Deparment Oslo University Hospital Oslo Norway
Department of Nursing and Midwifery Masaryk University Brno Czech Republic
Department of Obstetrics and Gynecology Paule de Viguier Hospital CHU Toulouse
Dept Midwifery Science University Lubeck Institute for Health Sciences Lubeck Germany
Finnish Society of Perinatology Turku University Hospital Turku University Turku Finland
Hôpitaux Universitaires de Strasbourg Université de Strasbourg Strasbourg France
Kingston Hospital Foundation Trust London UK
Santa Maria Hospital University of Lisbon Medical School Lisbon Portugal
UMR1295 CERPOP Toulouse 3 University Toulouse France
University Claude Bernard Lyon 1 Research on Healthcare Performance INSERM U1290
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032540
- 003
- CZ-PrNML
- 005
- 20230210132958.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/14767058.2021.1945577 $2 doi
- 035 __
- $a (PubMed)34470113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 245 00
- $a European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[Formula: see text] / $c Writing group:, I. Nunes, C. Dupont, S. Timonen, Guideline panel:, D. Ayres de Campos, V. Cole, C. Schwarz, A. Kwee, B. Yli, C. Vayssiere, GE. Roth, E. Gliozheni, Y. Savochkina, M. Ivanisevic, P. Janku, S. Timonen, G. Daskalakis, A. Beke, S. Santo, M. Druškovič, JJ. Duvekot, A. Farr, M. Dreyfus
- 520 9_
- $a OF RECOMMENDATIONS1. Oxytocin for induction or augmentation of labor should not be started when there is a previous scar on the body of the uterus (such as previous classical cesarean section, uterine perforation or myomectomy when uterine cavity is reached) or in any other condition where labor or vaginal delivery are contraindicated. (Moderate quality evidence +++-; Strong recommendation).2. Oxytocin should not be started before at least 1 h has elapsed since amniotomy, 6 h since the use of dinoprostone (30 min if vaginal insert) and 4 h since the use of misoprostol (Low quality evidence ++- -; Moderate recommendation).3. Cardiotocography (CTG) should be performed and a normal pattern without tachysystole should be documented for at least 30 min before oxytocin is used. Continuous CTG, with adequate monitoring of both fetal heart rate and uterine contractions, should be maintained for as long as oxytocin is used, and thereafter until delivery (Low ++- - to moderate +++- quality evidence; Strong recommendation).4. For labor induction, at least 1-h should be allowed after amniotomy before oxytocin infusion is started, to evaluate whether adequate uterine contractility has meanwhile ensued. For augmentation of labor, if the membranes are intact and there are conditions for a safe amniotomy, the latter should be considered before oxytocin is started (Very low quality evidence +- --; Weak recommendation).5. Oxytocin should be administered intravenously using the following regimen: 5 IU oxytocin diluted in 500 mL of 0.9% normal saline (NaCl) (each mL contains 10 mIU of oxytocin), in an infusion pump at increasing rates, as shown in Table 1, until a frequency of 3-4 contractions per 10 min is reached, a non-reassuring CTG pattern ensues, or maximum rates are reached (Low quality evidence ++ - -; Strong recommendation). If the frequency of contractions exceeds 5 in 10 min, the infusion rate should be reduced, even if a normal CTG pattern is present. With a non-reassuring CTG pattern, urgent clinical assessment by an obstetrician is indicated, and strong consideration should be given to reducing or stopping the oxytocin infusion. The minimal effective dose of oxytocin should always be used. (Low ++- - to Moderate +++- - quality evidence; Strong recommendation).[Table: see text]6. Use of oxytocin for induction and augmentation of labor should be regularly audited (Low quality evidence ++--; Strong recommendation).
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a císařský řez $7 D002585
- 650 12
- $a indukovaný porod $7 D007751
- 650 _2
- $a misoprostol $7 D016595
- 650 12
- $a uterotonika $x terapeutické užití $7 D010120
- 650 _2
- $a oxytocin $x terapeutické užití $7 D010121
- 650 _2
- $a perinatální péče $7 D018743
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nunes, Inês $u School of Medicine and Biomedical Sciences (ICBAS), University Hospital Center of Porto, CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal $1 https://orcid.org/0000000167093916
- 700 1_
- $a Dupont, Corinne $u University Claude Bernard Lyon 1, Research on Healthcare Performance (RESHAPE) INSERM U1290; AURORE Perinatal Network, Hospices Civils de Lyon, Croix-Rousse Hospital, Lyon, France
- 700 1_
- $a Timonen, Susanna $u Finnish Society of Perinatology, Turku University Hospital, Turku University, Turku, Finland
- 700 1_
- $a Ayres de Campos, Diogo $u Santa Maria Hospital, University of Lisbon Medical School, Lisbon, Portugal $1 https://orcid.org/0000000271366240
- 700 1_
- $a Cole, Vanessa $u Kingston Hospital Foundation Trust, London, UK
- 700 1_
- $a Schwarz, Christiane $u Dept. Midwifery Science, University Lubeck, Institute for Health Sciences, Lubeck, Germany
- 700 1_
- $a Kwee, Anneke $u Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 700 1_
- $a Yli, Branka $u Delivery Deparment, Oslo University Hospital, Oslo, Norway
- 700 1_
- $a Vayssiere, Christophe $u Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse; UMR1295 CERPOP (Centre for Epidemiology and Population Health Research), Team SPHERE (Study of Perinatal, Paedriatric and Adolescent Health: Epidemiological Research and Evaluation) Toulouse III University, Toulouse, France
- 700 1_
- $a Roth, Georges-Emmanuel $u Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France
- 700 1_
- $a Gliozheni, Elko $u Albanian Association of Perinatology, Department of Obstetrics and Gynecology, University Hospital of Obstetrics and Gynaecology 'Koco Gliozheni', Tirana, Albania
- 700 1_
- $a Savochkina, Yuliya $u Bielorussian Society of Human Reproduction, 5th Minsk City Hospital and Belarus Medical Academy of Postgraduate Education, Minsk, Belarus
- 700 1_
- $a Ivanisevic, Marina $u Croatian Association of Perinatal Medicine, University Clinic for Obstetrics and Gynecology, School of Medicine, Zagreb, Croatia
- 700 1_
- $a Janku, Petr $u Czech Society of Perinatology and Feto-Maternal Medicine, Department of Obstetrics and Gynecology, University Hospital Brno, Masaryk University Brno, Brno, Czech Republic; Department of Nursing and Midwifery, Masaryk University Brno, Czech Republic
- 700 1_
- $a Timonen, Susanna $u Finnish Society of Perinatology, Turku University Hospital, Turku University, Turku, Finland
- 700 1_
- $a Daskalakis, George $u Hellenic Society of Perinatal Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Beke, Artur $u Hungarian Society of Perinatology and Obstetric Anesthesiology, Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Santo, Susana $u Portuguese Society of Obstetrics and Maternal-Fetal Medicine, Santa Maria Hospital, University of Lisbon Medical School, Lisbon, Portugal
- 700 1_
- $a Druškovič, Mirjam $u Slovenia Medical Association - Society of Perinatal Medicine, Division of Obstetrics and Gynecology, UMC Ljubljana, Ljubljana, Slovenia
- 700 1_
- $a Duvekot, J J $u Dutch Society of Obstetrics and Gynecology, Department of Obstetrics, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
- 700 1_
- $a Farr, Alex $u Austrian Society for Pre- and Perinatal Medicine, Department of Obstetrics and Gynecology, Division of Obstetrics and feto-maternal Medicine, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000246289052
- 700 1_
- $a Dreyfus, Michel $u Societé Française de Medicine Perinatale, Service d'Obstétrique, Gynécologie et Médecine de la Reproduction, Centre Hospitalier Universitaire de Caen, Caen, France
- 710 2_
- $a Guideline panel:
- 773 0_
- $w MED00007048 $t The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians $x 1476-4954 $g Roč. 35, č. 25 (2022), s. 7166-7172
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34470113 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230210132939 $b ABA008
- 999 __
- $a ok $b bmc $g 1891357 $s 1183875
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 35 $c 25 $d 7166-7172 $e 20210901 $i 1476-4954 $m Journal of maternal-fetal & neonatal medicine $n J Matern Fetal Neonatal Med $x MED00007048
- LZP __
- $a Pubmed-20230120
